Clinical Trial Update: Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding stereotactic body radiation therapy to sorafenib improves outcomes in adults with hepatocellular carcinoma; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-07-03